Skip to main content
Clinical Trials/ISRCTN19762288
ISRCTN19762288
Completed
N/A

Treatment of child anxiety disorder in the context of maternal anxiety: a randomised controlled trial

niversity of Reading (UK)0 sites210 target enrollmentJanuary 4, 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mental and behavioural disorders
Sponsor
niversity of Reading (UK)
Enrollment
210
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 4, 2008
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Reading (UK)

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 21/03/2012
  • 1\. Aged 7 to 12 years
  • 2\. Primary diagnosis of DSM\-IV generalised anxiety disorder, social phobia, separation anxiety disorder , panic disorder/agoraphobia or specific phobia, co\-morbid with one of the previous disorders
  • 3\. Absence of significant physical or intellectual impairment (including autistic spectrum disorders)
  • 1\. Primary carer
  • 2\. Current maternal DSM\-IV anxiety disorder
  • 3\. Absence of severe comorbid disorder (e.g. severe major depressive disorder, psychosis, substance/alcohol dependence)
  • For both the mother and child:
  • Absence of psychotropic medication (or, if psychotropic medication is prescribed, it should have been at a stable dose for at least one month with agreement to maintain that dose throughout the study)
  • Previous inclusion criteria

Exclusion Criteria

  • 1\. Aged less than 7 or over 12 years
  • 2\. No primary diagnosis of DSM\-IV generalised anxiety disorder, social phobia, or separation anxiety disorder
  • 3\. Presence of significant physical or intellectual impairment (including autistic spectrum disorders)
  • 1\. Is not primary carer
  • 2\. Absence of current maternal DSM\-IV anxiety disorder
  • 3\. Presence of severe comorbid disorder (e.g. severe major depressive disorder, psychosis, substance/alcohol dependence)
  • For both the mother and child:
  • Presence of psychotropic medication at a stable dose for less than one month

Outcomes

Primary Outcomes

Not specified

Similar Trials